Internationalisation

 

Investment Opportunities in DACH

The 100m population of wealthy German-speaking countries is by far the largest market for healthcare services in Europe. What will be the trajectory for future consolidation, who are the players and what is the opportunity? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment. Speakers […]

2022 Health Care M&A Landscape

2021 has been a record year for deal activity and IPOs. But as multiples hit a ceiling, what will happen in 2022? Investors are keeping a watchful eye on inflation, rising wages, energy bills, and overall increased costs of living. The war in Ukraine, sanctions on Russian companies, particularly oil and gas has only added to market […]

Atrys: What’s the focus?

No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.

Fresenius Helios launches revolutionary primary care offer

Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.

Interview: Dirk Knüppel, Meine Radiologie

Imaging and radiology is hot at the moment - especially in Germany. The next five years are going to see a huge amount of consolidation according to Dirk Knüppel, CEO at EQT-backed Meine Radiologie & Blikk Holding (MRBH) and HBI 2022 panellist. HBI caught up with him to find out more about his group's plans to expand across Europe.

Turkish groups look for lira depreciation workarounds

The Turkish Lira has been consistently depreciating, losing three-quarters of its US dollar value in the last five years. HBI speaks with an operator source, as well as consultants and operators from Turkey, to find out their strategy to hedge against a worsening exchange rate.

Infermedica targets the USA for expansion

Infermedica, the Polish health tech start-up, will expand its US investments, thanks to the funding gained in a recent Series B financing round. HBI talks with Miłosz Wiciński, Business Development Executive at Infermedica, to learn more.

Orpea won’t stop nursing home M&A drive

Orpea's smaller PE-backed French rivals who are spilling out across Europe say they are not worried by the Orpea scandal. Colissee has just acquired in Portugal for the first time. HBI talks to the C-level at the French operator to learn more.

Eurofins to build lab hubs

After a strong performance in 2021, international lab group Eurofins plans to build diagnostic lab hubs, which will enable it to increase the volume of tested samples. HBI talks with the source close to the company to find out more.

Find Us